pharma-and-clinical-pharmacy-congress-2016_tracks

19 / 21

Notes:
Page 47
Pharma & Clinical Pharmacy Congress 2016
November 07-09, 2016
Volume 5 Issue 4(Suppl) Clin Pharmacol Biopharm
ISSN: 2167-065X CPB, an open access journal
conferenceseries .com
November 07-09, 2016 Las Vegas, Nevada, USA
4th International
Pharma & Clinical Pharmacy Congress
Thaisa Marinho Dezani et al., Clin Pharmacol Biopharm 2016, 5:4(Suppl)
Permeability study using the single-pass intestinal perfusion in rats: Is the zidovudine a substrate
for P-gp?
Thaisa Marinho Dezani, Andre Bersani Dezani and Cristina Helena dos Reis Serra
University of Sao Paulo, Brazil
The small intestine is the main site of absorption for many drugs orally administered and it depends on solubility and
permeability characteristics of the compound to reach the bloodstream. Many drugs are absorbed mainly by trans-cellular
passive diffusion, but the presence of efflux transporters, such as P-glycoprotein (P-gp) can hamper the permeation. The oral
bioavailability of zidovudine (AZT) is not complete and among other factors, efflux transport can be involved on its permeation
process. Thus, this study aims to evaluate the permeability of AZT and its interaction with P-gp using the single-pass intestinal
perfusion (SPIP) in rats. Male Wistar rats were anesthetized with ketamine-xylazine mixture. Blank perfusion solution pH
6.5 at 37°C was pumped into jejunum to clean any residual debris. Then, the perfusion solution containing AZT was pumped
into intestine and samples were collected from the distal portion. The same procedure was made for AZT with P-gp inhibitor
verapamil and all samples were quantified by HPLC method. Metoprolol and ranitidine were used as permeability marker
substances in this study. The effective permeability (Peff) of AZT was 4.37 (±0.45)x10-5 cm/s. For AZT with verapamil, the Peff
was 5.44 (±0.39)x10-5 cm/s. These results showed that AZT has an interaction with P-gp. That is in accordance with other in
vitro and ex vivo studies reported in the literature, which can explain the variability on the oral bioavailability. The comparison
between AZT and AZT with verapamil results led to conclude that AZT had its permeability increased when verapamil was
used. Thus, AZT can have an interaction with P-gp which may influence on its permeability and contribute for its incomplete
bioavailability.
Biography
Thaisa Marinho Dezani has completed her Master’s degree in 2012 and since then, she is completing her PhD thesis related to permeability studies using different
methods as in situ, ex vivo and in vitro models. Her research field also includes “Solubility, biopharmaceutical classification systems (BCS and BDDCS), dissolution
studies and ADME prediction”. She was a Visiting Scholar at Benet Lab, University of California San Francisco, USA.